The finding that MMP-9, as other MMPs, also cleaves intracellular substrates, and shows different responsiveness to inflammatory molecules and therapeutic inhibitors depending on cell type and location, greatly complicates our understanding of the roles of MMP-9 in MS. This evidence concerns the gene MMP9 and myeloid sarcoma.